- Status:
- Red
- Decision Date:
- November 2018
Comments
RED 1,2: NICE TA682 - Preventing migraines in adults. (Decision date - April 2021)
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
search again